← SynDRA
BMS-754807
SynDRA canonical compound SYN0020149 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | IGF1R |
| Mechanism of action | IGF-1 inhibitor |
All known targets
Mechanisms of action (all sources)
- IGF-1 inhibitor
- IGF1R INHIBITOR
- Insulin-like growth factor I receptor inhibitor
- INSR INHIBITOR
- Insulin receptor inhibitor
- AKT1 INHIBITOR
Cross-references
Synonyms
- BMS-754807-01
- BMS754807
- BMS 754807
- UNII-W9E3353E8J
- CHEMBL575448
- CHEBI:88339
- W9E3353E8J
- 1-{4-[(3-cyclopropyl-1H-pyrazol-5-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl}-N-(6-fluoropyridin-3-yl)-2-methyl-L-prolinamide
- W-204348
- J-501009
- 2-Pyrrolidinecarboxamide, 1-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]-N-(6-fluoro-3-pyridinyl)-2-methyl-, (2S)-;2-Pyrrolidinecarboxamide, 1-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]-N-(6-fluoro-3-pyridin
- RefChem:569725
- DUAL IGF-1R/INSR INHIBITOR BMS-754807
- MFCD18633202
- namide
- C23H24FN9O
- MLS006011175
- GTPL7952
- orb1305620
- SCHEMBL1810808
- SCHEMBL29363253
- EX-A711
- BDBM107000
- GLXC-02859
- HMS3740K13
- BDBM50299148
- NSC758243
- NSC799364
- s1124
- BMS 754807 [WHO-DD]
- AKOS015949394
- BMS754807?
- CCG-269352
- CS-0608
- EBC-220046
- FB64960
- NSC-758243
- NSC-799364
Look up BMS-754807 in the interactive SynDRA portal →